Video

Educated Patient® Skin Cancer Summit: June 26, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient Skin Cancer Summit on demand.

Related Videos
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with grey hair.
Image of bald man in suit.
Image of woman with dark hair, smiling.
Image of woman with brown hair.
Image of man with grey hair.
Image of woman with black hair.
Related Content
"FDA" text.
January 2nd 2025

Cancer Therapies Approved by the FDA in December 2024

Darlene Dobkowski, MA
The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Image of woman with blondish hair.
December 30th 2024

Empowering Patients With Cancer Through Clear Clinical Trial Communication

Darlene Dobkowski, MA
A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and potential side effects.
Top Cancer Headlines from 2023
January 2nd 2024

Top Cancer Headlines from 2023

Alex Biese Brielle Benyon
From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.
white background with black text indicating FDA
December 27th 2024

Subcutaneous Opdivo Receives FDA Approval for Advanced, Metastatic Solid Tumors

Darlene Dobkowski, MA
Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors.
Illustration of a person with a tumor in their left breast.
December 26th 2024

Top 5 Stories from the 2024 San Antonio Breast Cancer Symposium

Darlene Dobkowski, MA
CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer, in addition to treatment strategies.